Pamela Stephenson Insider Profile
4 Followers
Pamela Stephenson, CCO at Disc Medicine, holds 81.00K shares in Disc Medicine (Ticker: IRON), holds 0.00 shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 0.00 shares in Albireo Pharma (Ticker: ALBO). Most recently, Pamela Stephenson Sold ― shares of Disc Medicine on Feb 17, 2026 for an estimated value of $347.68K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-9.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Pamela Stephenson's holdings
Insider Roles
CCO
Roles that Pamela Stephenson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pamela Stephenson
Pamela Stephenson's Trading History
Disc Medicine
Feb 17, 2026
CCO
Informative Sell
347.68K
$5.67M
Zynerba Pharmaceuticals
Oct 11, 2023
―
Uninformative Sell
―
$0.00
Albireo Pharma
Mar 02, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Pamela Stephenson's performance on stock
You May Also Like
Pamela Stephenson insider profile FAQ
What is the percentage of profitable transactions made by Pamela Stephenson?
The percentage of profitable transactions made by Pamela Stephenson is 0%.
What is the average return per transaction made by Pamela Stephenson?
The average return per transaction made by Pamela Stephenson is -9.80%.
What stocks does Pamela Stephenson hold?
Pamela Stephenson holds: IRON, ZYNE, ALBO stocks.
What was Pamela Stephenson’s latest transaction?
Pamela Stephenson latest transaction was an Informative Sell of $347.68K.
What was Pamela Stephenson's most profitable transaction?
Pamela Stephenson’s most profitable transaction was an Informative Sell of IRON stock on February 17, 2026. The return on the trade was -6.80%.
What is Pamela Stephenson's role in Disc Medicine?
Pamela Stephenson's role in Disc Medicine is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.